Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma

被引：14

作者：

Dai, ZhiJian ^{[1
]}

Pan, Shenhua ^{[2
]}

Chen, Congxi ^{[1
]}

Cao, Longhe ^{[1
]}

Li, Xianhui ^{[1
]}

Chen, Xiaofeng ^{[1
]}

Su, Xiaoqing ^{[1
]}

Lin, Sen ^{[1
]}

机构：

[1] Wenzhou Med Univ, Affiliated Hosp 3, Dept Otolaryngol, Wenzhou 325200, Peoples R China

[2] Wenzhou Med Univ, Affiliated Hosp 3, Dept Pathol, Wenzhou, Peoples R China

来源：

TUMOR BIOLOGY | 2016年 / 37卷 / 04期

关键词：

Recurrent; Nasopharyngeal carcinoma; Succinate dehydrogenase subunit B; Pyruvate dehydrogenase kinase 1; Prognosis; PHASE-III; PDK1; SDHB; EXPRESSION; CANCER; CHEMOTHERAPY; RADIOTHERAPY; METASTASIS; MUTATIONS; SURVIVAL;

D O I：

10.1007/s13277-015-4107-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Succinate dehydrogenase subunit B (SDHB) and pyruvate dehydrogenase kinase 1 (PDK1) play key roles in the regulation of growth and survival of various cancers. This study aimed to investigate expression of SDHB and PDK1 in recurrent nasopharyngeal carcinoma (rNPC) tissues and analyzed the association of SDHB and PDK1 expression with the clinical significance and potential prognostic implication of rNPC. Immunohistochemistry was performed to determine the expression of SDHB and PDK1 in tissues in primary NPC (pNPC) and rNPC patients. Our results revealed that expression of SDHB in rNPC was significantly lower than that in pNPC, while the expression of PDK1 was higher compared to pNPC. The expression levels of SDHB and PDK1 were associated with T stage, N stage, clinical stage, and metastasis of rNPC. Survival analysis showed that patients with low SDHB expression had a significantly shorter overall survival time than those with high SDHB expression. Patients with high PDK1 expression had a shorter survival time than patients with low PDK1 expression. Multivariate analysis showed that the expression of SDHB and PDK1 was an independent predictor for the survival of patients with rNPC. Our results demonstrated that down-regulation of SDHB and up-regulation of PDK1 may be novel biomarkers for predicting advanced tumor progression and unfavorable prognosis in rNPC patients.

引用

页码：5145 / 5152

页数：8

共 33 条

[1] An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours [J].

Ahmed, N. ;

Riley, C. ;

Quinn, M. A. .

BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1415-1424

[2]

[Anonymous], 2020, CA Cancer J Clin, DOI [DOI 10.3322/caac.20115, DOI 10.3322/CAAC.21590]

[3] Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice [J].

Bayascas, JR ;

Leslie, NR ;

Parsons, R ;

Fleming, S ;

Alessi, DR .

CURRENT BIOLOGY, 2005, 15 (20) :1839-1846

[4] SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling [J].

Blank, Annika ;

Schmitt, Anja M. ;

Korpershoek, Esther ;

van Nederveen, Francien ;

Rudolph, Thomas ;

Weber, Nicole ;

Strebel, Raeto Thomas ;

de Krijger, Ronald ;

Komminoth, Paul ;

Perren, Aurel .

[5] Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers [J].

Cao, Zhang ;

Song, Jae Hwi ;

Kang, Young Whi ;

Yoon, Jung Hwan ;

Nam, Suk Woo ;

Lee, Jung Young ;

Park, Won Sang .

PATHOLOGY INTERNATIONAL, 2010, 60 (08) :559-565

[6] PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound [J].

Cen, L. ;

Hsieh, F-C ;

Lin, H-J ;

Chen, C-S ;

Qualman, S. J. ;

Lin, J. .

BRITISH JOURNAL OF CANCER, 2007, 97 (06) :785-791

[7] Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial [J].

Chan, ATC ;

Teo, PML ;

Ngan, RK ;

Leung, TW ;

Lau, WH ;

Zee, B ;

Leung, SF ;

Cheung, FY ;

Yeo, W ;

Yiu, HH ;

Yu, KH ;

Chiu, KW ;

Chan, DT ;

Mok, T ;

Yuen, KT ;

Mo, F ;

Lai, M ;

Kwan, WH ;

Choi, P ;

Johnson, PJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2038-2044

[8] Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study [J].

Doyle, Leona A. ;

Nelson, Dylan ;

Heinrich, Michael C. ;

Corless, Christopher L. ;

Hornick, Jason L. .

HISTOPATHOLOGY, 2012, 61 (05) :801-809

[9] Nasopharyngeal carcinomas:: analysis of patient, tumor and treatment characteristics determining outcome [J].

Erkal, HS ;

Serin, M ;

Çakmak, A .

RADIOTHERAPY AND ONCOLOGY, 2001, 61 (03) :247-256

[10] Signalling pathways in succinate dehydrogenase B-associated renal carcinoma [J].

Fleming, Stewart ;

Mayer, Nick J. ;

Vlatkovic, Ljiljana J. ;

McLean, Joanne ;

McConachie, Michelle ;

Baty, David .

HISTOPATHOLOGY, 2014, 64 (04) :477-483

← 1 2 3 4 →